Tributary Capital Management’s Medtronic MDT Stock Holding History

Tributary Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-376	Closed	-$30K	–	193
2024 Q4	$30K	Hold	376	–	–	﹤0.01%	181
2024 Q3	$33.9K	Hold	376	–	–	﹤0.01%	177
2024 Q2	$29.6K	Buy	376 +2	+0.5%	+$164	﹤0.01%	182
2024 Q1	$32.6K	Buy	+374	New	+$31.9K	﹤0.01%	179
2019 Q1	–	Sell	-300	Closed	-$27K	–	232
2018 Q4	$27K	Buy	+300	New	+$28K	﹤0.01%	239
2018 Q2	–	Sell	-300	Closed	-$24K	–	240
2018 Q1	$24K	Buy	+300	New	+$24.7K	﹤0.01%	229
2017 Q4	–	Sell	-300	Closed	-$23K	–	218
2017 Q3	$23K	Buy	+300	New	+$24.9K	﹤0.01%	228
2013 Q4	–	Sell	-325	Closed	-$17K	–	209
2013 Q3	$17K	Sell	325 -92,400	-100%	-$4.97M	﹤0.01%	197
2013 Q2	$4.77M	Buy	+92,725	New	+$4.58M	0.78%	20

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tributary Capital Management's MDT Position: Q1 2025 in Review

Tributary Capital Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 376 shares — an estimated $30K sold.

Tributary Capital Management first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $4.77M in Q2 2013. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

Tributary Capital Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
Tributary Capital Management sold 376 Medtronic shares in Q1 2025, an estimated $30K.
Tributary Capital Management first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
Tributary Capital Management's Medtronic position peaked at $4.77M in Q2 2013.
2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Tributary Capital Management's 13F filing for Q1 2025, filed 2 May 2025.